Although IFN-α was initially used to treat HES patients with high myeloproliferative scores (28), it is also known to act on T cell polarization, and has specifically been to shown to reduce IL-5 production by clonal CD3−CD4+ cells in vitro (29). Here, IFNA2 is linked to hypereosinophilic syndrome.